HEADER TRANSPORT PROTEIN 02-NOV-06 2NRM TITLE S-NITROSYLATED BLACKFIN TUNA MYOGLOBIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYOGLOBIN; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THUNNUS ATLANTICUS; SOURCE 3 ORGANISM_TAXID: 48168 KEYWDS S-NITROSYLATION, MYOGLOBIN, GLOBIN, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.R.SCHREITER,M.M.RODR GUEZ,A.WEICHSEL,W.R.MONTFORT,J.BONAVENTURA REVDAT 6 30-AUG-23 2NRM 1 REMARK LINK REVDAT 5 04-APR-18 2NRM 1 REMARK REVDAT 4 13-JUL-11 2NRM 1 VERSN REVDAT 3 24-FEB-09 2NRM 1 VERSN REVDAT 2 30-OCT-07 2NRM 1 JRNL REVDAT 1 08-MAY-07 2NRM 0 JRNL AUTH E.R.SCHREITER,M.M.RODRIGUEZ,A.WEICHSEL,W.R.MONTFORT, JRNL AUTH 2 J.BONAVENTURA JRNL TITL S-NITROSYLATION-INDUCED CONFORMATIONAL CHANGE IN BLACKFIN JRNL TITL 2 TUNA MYOGLOBIN. JRNL REF J.BIOL.CHEM. V. 282 19773 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17488722 JRNL DOI 10.1074/JBC.M701363200 REMARK 2 REMARK 2 RESOLUTION. 1.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 51131 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.134 REMARK 3 R VALUE (WORKING SET) : 0.133 REMARK 3 FREE R VALUE : 0.157 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2684 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.09 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.12 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3577 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.86 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE SET COUNT : 157 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1097 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 198 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 8.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.25000 REMARK 3 B22 (A**2) : -0.12000 REMARK 3 B33 (A**2) : -0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.06000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.031 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.031 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.020 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.888 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.979 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.970 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1430 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 960 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1961 ; 1.541 ; 2.090 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2377 ; 0.966 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 195 ; 9.043 ; 5.205 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 49 ;37.041 ;25.510 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 243 ;10.732 ;15.062 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 3 ;10.760 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 211 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1614 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 253 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 337 ; 0.237 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1036 ; 0.175 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 683 ; 0.200 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 633 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 120 ; 0.166 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.117 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 38 ; 0.164 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.118 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1141 ; 1.700 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 353 ; 0.662 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1402 ; 1.992 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 656 ; 2.740 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 551 ; 3.450 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2883 ; 1.376 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 211 ; 8.401 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2350 ; 3.516 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2NRM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040217. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51387 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.090 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06100 REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.36500 REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1MYT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM/SODIUM TARTRATE, 0.1 M REMARK 280 SODIUM CITRATE, AND 2.0 M AMMONIUM SULFATE, PH 5.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 193K, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.96600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 9 CD CE NZ REMARK 480 LYS A 109 CD CE NZ REMARK 480 GLY A 147 CA C O OXT REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 109 O HOH A 427 2.10 REMARK 500 O HOH A 369 O HOH A 384 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY A 147 N GLY A 147 CA 0.105 REMARK 500 GLY A 147 C GLY A 147 OXT -0.117 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 17 75.55 -154.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 148 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 89 NE2 REMARK 620 2 HEM A 148 NA 91.4 REMARK 620 3 HEM A 148 NB 92.9 90.2 REMARK 620 4 HEM A 148 NC 92.0 176.6 90.0 REMARK 620 5 HEM A 148 ND 90.8 89.2 176.3 90.4 REMARK 620 6 HOH A 305 O 175.5 92.1 89.9 84.5 86.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 148 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 304 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2NRL RELATED DB: PDB REMARK 900 BLACKFIN TUNA MYOGLOBIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE OF THIS PROTEIN IS NOT AVAILABLE AT REMARK 999 ANY SEQUENCE DATABASE AT THE TIME OF PROCESSING. DBREF 2NRM A 1 147 PDB 2NRM 2NRM 1 147 SEQRES 1 A 147 ACE ALA ASP PHE ASP ALA VAL LEU LYS SNC TRP GLY PRO SEQRES 2 A 147 VAL GLU ALA ASP TYR THR THR ILE GLY GLY LEU VAL LEU SEQRES 3 A 147 THR ARG LEU PHE LYS GLU HIS PRO GLU THR GLN LYS LEU SEQRES 4 A 147 PHE PRO LYS PHE ALA GLY ILE ALA GLN ALA ASP ILE ALA SEQRES 5 A 147 GLY ASN ALA ALA VAL SER ALA HIS GLY ALA THR VAL LEU SEQRES 6 A 147 LYS LYS LEU GLY GLU LEU LEU LYS ALA LYS GLY SER HIS SEQRES 7 A 147 ALA ALA ILE LEU LYS PRO LEU ALA ASN SER HIS ALA THR SEQRES 8 A 147 LYS HIS LYS ILE PRO ILE ASN ASN PHE LYS LEU ILE SER SEQRES 9 A 147 GLU VAL LEU VAL LYS VAL MET GLN GLU LYS ALA GLY LEU SEQRES 10 A 147 ASP ALA GLY GLY GLN THR ALA LEU ARG ASN VAL MET GLY SEQRES 11 A 147 ILE ILE ILE ALA ASP LEU GLU ALA ASN TYR LYS GLU LEU SEQRES 12 A 147 GLY PHE SER GLY MODRES 2NRM SNC A 10 CYS S-NITROSO-CYSTEINE HET ACE A 1 3 HET SNC A 10 22 HET HEM A 148 49 HET GOL A 301 12 HET GOL A 302 12 HET GOL A 303 6 HET GOL A 304 12 HETNAM ACE ACETYL GROUP HETNAM SNC S-NITROSO-CYSTEINE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM GOL GLYCEROL HETSYN HEM HEME HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 ACE C2 H4 O FORMUL 1 SNC C3 H6 N2 O3 S FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 GOL 4(C3 H8 O3) FORMUL 7 HOH *198(H2 O) HELIX 1 1 ALA A 2 LYS A 9 1 8 HELIX 2 2 TRP A 11 ALA A 16 1 6 HELIX 3 3 ASP A 17 HIS A 33 1 17 HELIX 4 4 HIS A 33 LYS A 38 1 6 HELIX 5 5 ALA A 47 ILE A 51 5 5 HELIX 6 6 ASN A 54 ALA A 74 1 21 HELIX 7 7 HIS A 78 LYS A 92 1 15 HELIX 8 8 ILE A 97 ALA A 115 1 19 HELIX 9 9 ASP A 118 LEU A 143 1 26 LINK C ACE A 1 N ALA A 2 1555 1555 1.32 LINK C LYS A 9 N ASNC A 10 1555 1555 1.33 LINK C LYS A 9 N BSNC A 10 1555 1555 1.33 LINK C LYS A 9 N CSNC A 10 1555 1555 1.34 LINK C CSNC A 10 N TRP A 11 1555 1555 1.32 LINK C BSNC A 10 N TRP A 11 1555 1555 1.33 LINK C ASNC A 10 N TRP A 11 1555 1555 1.33 LINK NZ LYS A 114 O1 AGOL A 304 1555 1555 1.93 LINK NE2 HIS A 89 FE HEM A 148 1555 1555 2.07 LINK FE HEM A 148 O HOH A 305 1555 1555 2.08 SITE 1 AC1 20 LEU A 39 PHE A 40 LYS A 42 HIS A 60 SITE 2 AC1 20 THR A 63 LEU A 85 SER A 88 HIS A 89 SITE 3 AC1 20 HIS A 93 ILE A 95 ASN A 99 PHE A 100 SITE 4 AC1 20 HOH A 305 HOH A 319 HOH A 354 HOH A 423 SITE 5 AC1 20 HOH A 426 HOH A 452 HOH A 480 HOH A 489 SITE 1 AC2 5 LYS A 83 GLU A 142 LEU A 143 HOH A 352 SITE 2 AC2 5 HOH A 487 SITE 1 AC3 8 ALA A 90 LYS A 94 PRO A 96 PHE A 145 SITE 2 AC3 8 HOH A 311 HOH A 340 HOH A 413 HOH A 498 SITE 1 AC4 5 ASP A 17 TYR A 18 THR A 19 LYS A 66 SITE 2 AC4 5 HOH A 318 SITE 1 AC5 4 GLU A 113 LYS A 114 HOH A 368 HOH A 457 CRYST1 33.943 51.932 38.899 90.00 103.75 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029461 0.000000 0.007210 0.00000 SCALE2 0.000000 0.019256 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026466 0.00000 HETATM 1 C ACE A 1 15.644 15.695 7.323 1.00 19.68 C ANISOU 1 C ACE A 1 2525 2248 2701 -167 -249 -84 C HETATM 2 O ACE A 1 15.047 14.927 6.560 1.00 19.10 O ANISOU 2 O ACE A 1 2420 2076 2759 -285 -444 -96 O HETATM 3 CH3 ACE A 1 14.955 16.644 8.256 1.00 19.82 C ANISOU 3 CH3 ACE A 1 2610 2217 2705 -295 -225 -177 C